DSGN
insider transactionsDesign Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-562.6K
0 buy · 562.6K sell
Net value · 365d
-$3.0M
$0 in · $3.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
2
0 buy · 562.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own New
-
Grant·A
Director
$0
60.0K sh
Own New
-
Grant·A
Director
$0
45.0K sh
Own New
-
Grant·A
Chief Accounting Officer
$0
150.0K sh
Own New
-
Grant·A
Shah Pratik KEY
President, CEO and Chairperson
$0
750.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
250.0K sh
Own New
-
Grant·A
Chief Operating Officer
$0
375.0K sh
Own New
-
Grant·A
Shah Pratik KEY
President, CEO and Chairperson
$0
525.0K sh
Own New
-
Grant·A
Shah Pratik KEY
President, CEO and Chairperson
$0
525.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
15.8K sh
Own New
-
Sell·S
Director
$1.8M
345.0K sh · $5.25
Own -12%
-
Sell·S
Director
$1.1M
217.6K sh · $5.25
Own -18%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Gover Justin D. | Grant A | 30.0K | $0 |
| Jun 9, 2026 | LAPPE RODNEY W | Grant A | 30.0K | $0 |
| Jun 9, 2026 | Shapiro David | Grant A | 30.0K | $0 |
| Jun 9, 2026 | Schmid John P. | Grant A | 30.0K | $0 |
| Jun 9, 2026 | George Simeon | Grant A | 30.0K | $0 |
| Jun 9, 2026 | Behanna Heather | Grant A | 30.0K | $0 |
| Mar 31, 2026 | Shapiro David | Grant A | 7.5K | $0 |
| Mar 31, 2026 | Shapiro David | Grant A | 60.0K | $0 |
| Jan 2, 2026 | Gover Justin D. | Grant A | 45.0K | $0 |
| Jan 2, 2026 | Burgess Julie | Grant A | 150.0K | $0 |
| Jan 2, 2026 | Shah Pratik KEY | Grant A | 750.0K | $0 |
| Jan 2, 2026 | Storgard Chris | Grant A | 250.0K | $0 |
| Jan 2, 2026 | Jeffries Sean | Grant A | 375.0K | $0 |
| Dec 9, 2025 | Shah Pratik KEY | Grant A | 525.0K | $0 |
| Dec 9, 2025 | Shah Pratik KEY | Grant A | 525.0K | $0 |
| Sep 9, 2025 | Gover Justin D. | Grant A | 30.0K | $0 |
| Sep 9, 2025 | Gover Justin D. | Grant A | 15.8K | $0 |
| Aug 13, 2025 | William Arsani | Sell S | 345.0K | $1.8M |
| Aug 13, 2025 | William Arsani | Sell S | 217.6K | $1.1M |
About DSGN insider trading
This page tracks insider transactions for Design Therapeutics, Inc. (DSGN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.